Long-term Follow-up in Patients Affected With Acrofacial Vitiligo

Vitiligo Clinical Trial

Official title:

Long-term Ten Years Follow-up in Patients Affected With Acrofacial Vitiligo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT01459055
• Other study ID #: ACRO01
• Status: Not yet recruiting
• Phase: N/A
• First received: October 21, 2011
• Last updated: May 2, 2016
• Start date: May 2016
• Est. completion date: August 2020

Study information

• Verified date: May 2016
• Source: Irmandade da Santa Casa de Misericordia de Curitiba
• Contact: Caio Cesar C Castro, MD, PhD
• Phone: 00554135682036
• Email: caio.castro[@]pucpr.br
• Is FDA regulated: No
• Health authority: Brazil: Ethics Committee
• Study type: Observational

Clinical Trial Summary

Acrofacial vitiligo is a clinical form of vitiligo characterized by macules in distal digits, periorificial-facial and ano-genital areas. Vitiligo European Task Force classifies vitiligo as generalized or localized; generalized vitiligo may be further sub-divided into acrofacial, vulgaris and universalis, and localized vitiligo, into segmental and focal. Some authors do not believe that acrofacial is a real vitiligo clinical form, considering it as an initial form of vulgaris vitiligo. The aim of this study is to follow early- diagnosed acrofacial patients during ten years in order to define if these patients will maintain this clinical form or will evolute to a more severe clinical form.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 100
• Est. completion date: August 2020
• Est. primary completion date: January 2017
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. Patients of both genders, aged older than years, able to understand and provide written informed consent and able to allow compliance at the treatment and the requirements of the protocol;

2. Presence of acrofacial vitiligo;

3. Able to comprehend and willing to provide written informed consent in accordance with institutional and regulatory guidelines.

Exclusion Criteria:

1- Subjects assessed as not suitable for the study in the opinion of the investigator

2 -Inability to complete survey

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Vitiligo

Locations

Country	Name	City	State
Brazil	Irmandade da Santa Casa de Misericórdia de Curitiba	Curitiba	Parana

Sponsors (1)

Lead Sponsor	Collaborator
Irmandade da Santa Casa de Misericordia de Curitiba

Country where clinical trial is conducted

Brazil,